StonvexLoading…
StonvexStonvexStonvexCore line items from SMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-30 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.81B | $354.40M | $3.41B | $3.03B |
Operating Income | $380.00M | $-21.80M | $358.60M | $508.70M |
Net Income | $113.60M | $-125.00M | $145.20M | $297.10M |
EPS (Diluted) | $1.93 | $-2.16 | $2.47 | $5.07 |
Total Assets | $3.41B | $3.03B | $2.74B | $3.09B |
Total Liabilities | $3.70B | $3.53B | $3.10B | $3.26B |
Cash & Equivalents | $6.20M | $8.30M | $32.80M | $51.10M |
Free Cash Flow OCF − CapEx | $-189.00M | $-390.40M | $273.90M | $142.70M |
Shares Outstanding | 58.20M | 58.00M | 57.80M | 57.70M |